Stammdaten
Unternehmen & Branche
| Name | Semnur Pharmaceuticals, Inc. |
|---|---|
| Ticker | SMNR |
| CIK | 0001913577 |
| Boerse | US |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 81686G113 |
|---|---|
| ISIN | US81686G1132 |
| Typ | Common Stock |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -160,416,000 | -0.78 | 1,346,000 | -20,750,000 | |
| 2025-09-30 | 10-Q | -152,594,000 | -0.76 | 774,000 | -14,593,000 | |
| 2025-06-30 | 10-Q | -999,000 | 562,462 | -44,448,000 | ||
| 2025-03-31 | 10-Q | -665,000 | 9,147,903 | -43,449,000 | ||
| 2024-12-31 | 10-K | -167,306 | -0.02 | 6,684,000 | -42,784,000 | |
| 2024-10-02 | 10-K | 50,000,000 | ||||
| 2024-10-02 | 10-Q | 50,000,000 | ||||
| 2024-09-30 | 10-Q | -1,298,000 | -0.01 | 8,924,547 | -42,008,000 | |
| 2024-06-30 | 10-Q | -1,110,000 | 52,115,789 | -40,710,000 | ||
| 2024-03-31 | 10-Q | -1,506,000 | 51,347,261 | -39,600,000 | ||
| 2024-02-22 | 10-K | 50,000,000 | ||||
| 2024-02-22 | 10-Q | 50,000,000 | ||||
| 2023-12-31 | 10-K | 632,536 | 50,687,403 | -38,094,000 | ||
| 2023-09-30 | 10-Q | 630,586 | 90,146,984 | -7,931,846 | ||
| 2023-06-30 | 10-Q | 457,709 | 88,189,555 | -6,586,203 | ||
| 2023-03-31 | 10-Q | -1,009,102 | 86,957,511 | -5,193,053 | ||
| 2022-12-31 | 10-K | -419,390 | 86,279,436 | -3,271,305 | ||
| 2022-09-30 | 10-Q | 307,468 | 85,763,266 | -1,860,298 | ||
| 2022-06-30 | 10-Q | -30,847 | 85,527,298 | -1,672,505 | ||
| 2022-03-31 | 10-Q | -11,343 | 441,882 | 13,657 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-09-23 | Scilex Holding Co | 10% Owner | Open Market Sale | -554,849 | 16.00 | -8,877,584.00 | -8,9% | |
| 2025-09-23 | Scilex Holding Co | 10% Owner | Open Market Sale | -11,945,151 | 16.00 | -191,122,416.00 | -191,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.